NCT06457854View on ClinicalTrials.gov

Real-life Experience in Brazil in Patients With Castration-resistant Prostate Cancer Treated With Olaparib+Abiraterone

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

January 1, 2025

Primary Completion Date

February 4, 2025

Study Completion Date

February 4, 2025

Conditions
Prostatic Neoplasms
Trial Locations (5)

41950640

Clínica AMO, Salvador

59062-000

Liga Norte Rio Grandense Contra o Câncer, Natal

97015-450

Clínica Viver, Santa Maria

01327-001

Hospital Alemão Oswaldo Cruz, São Paulo

05652900

Hospital Albert Einstein, São Paulo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY